Current gastroenterology reports · 2025
Digital and Conventional Behavioral Therapies for Neurogastroenterology and Motility Disorders.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dave Pooja N, Kinsinger Sarah
Аннотация
PURPOSE OF REVIEW: Brain-gut behavior therapies (BGBTs) comprise of several behavioral and psychological therapies such as cognitive-behavioral therapy or gut-directed hypnotherapy that are effective at improving symptom management and quality of life for patients with a range of neurogastroenterology and motility disorders. This review highlights recent advances in BGBT approaches, including novel delivery methods to improve access to care.
RECENT FINDINGS: Traditional BGBT approaches have evolved to more effectively target GI-specific psychological processes, with exposure techniques and mindfulness-based skills emerging as important elements of treatment. BGBTs are also being delivered in new ways, including digital formats, to expand access to care. Digital therapeutics show promise; however, feasibility of these tools in clinical practice remains unclear. BGBTs continue to evolve to address the complex needs of patients with Disorders of Gut-Brain Interaction (DGBI) and are being applied more broadly to treat the full spectrum of DGBI conditions. Novel delivery methods show promise; however, further research is needed to identify real-world effectiveness of digital treatments and to identify patients most likely to benefit.
RECENT FINDINGS: Traditional BGBT approaches have evolved to more effectively target GI-specific psychological processes, with exposure techniques and mindfulness-based skills emerging as important elements of treatment. BGBTs are also being delivered in new ways, including digital formats, to expand access to care. Digital therapeutics show promise; however, feasibility of these tools in clinical practice remains unclear. BGBTs continue to evolve to address the complex needs of patients with Disorders of Gut-Brain Interaction (DGBI) and are being applied more broadly to treat the full spectrum of DGBI conditions. Novel delivery methods show promise; however, further research is needed to identify real-world effectiveness of digital treatments and to identify patients most likely to benefit.